2017: Ivanka Trump’s business ties in China are shrouded in secrecy
“Information that once routinely appeared in private trade tracking data has vanished, leaving the identities of companies involved in 90% of shipments unknown.” latimes.com/business/la-fi…
In July 2018, The Trump Administration imposed an additional 25 percent tariff on $34 billion worth of Chinese goods.
Among the sectors affected were nuclear reactors, boats and aircraft, but clothing was exempted. politico.com/story/2018/07/…
RNC chairwoman Ronna McDaniel tested positive for COVID-19 on Wednesday but made no mention of it in a Fox News appearance the next day businessinsider.com/republican-par…
JPMorgan Chase & Co <JPM.N> has agreed to pay more than $920 million and admitted to wrongdoing to settle federal U.S. market manipulation probes into its trading of metals futures and Treasury securities, the U.S. authorities said on Tuesday. reuters.com/article/us-jp-…
Utilizing federal executive power to directly and intentionally stifle competition (Huawei) in favor of a state-sponsored competitor (Cisco) is literally how fascism works. Many people in Trump’s close circle went to work for Cisco.
Trump announces 'surge' of federal officers to Chicago as he campaigns on 'law and order' mantle cnn.com/2020/07/22/pol…
Federal Officers Hit Portland Mayor With Tear Gas
Mayor Ted Wheeler denounced federal officers for an “egregious overreaction.” Some protesters mocked him, recalling the city police’s use of tear gas on demonstrators.
Convalescent plasma (CP) therapy, which uses blood plasma from recovered COVID-19 patients, shows promise during small random blind study in treating the disease sciencetimes.com/articles/25236…
Coronavirus: low antibody levels raise questions about reinfection risk
Scientists in Shanghai say some recovered patients show no signs of the neutralizing proteins, could have implications for vaccine development and herd immunity scmp.com/news/china/sci…
Human testing beginning on second coronavirus vaccine candidate, a DNA vaccine developed by Inovio. The first vaccine to begin human trials is an mRNA vaccine developed by Moderna